Clinical trial
Effects of KDT501 on Metabolic Features in Insulin Resistant Subjects
NCT02444910 is registered in ClinicalTrials.gov with KinDex Pharmaceuticals, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of KDT501 on Metabolic Features in Insulin Resistant Subjects
- Lead sponsor
- KinDex Pharmaceuticals, Inc.
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- April 30, 2015
- Completion date
- November 30, 2015
- Enrollment
- 9 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.